Bayer

Name

Bayer

Legal name

Bayer AG

Website

https://bayer.com

Company type

Public

Founded year

1863

Operating status

Operating

Headcount range

5,001–10,000 employees

Ownership category

akta.pro rank

Product category

Pharmaceuticals and Life Sciences

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Women’s Health & Reproductive Specialty Pharmaceuticals (HLAIACAN)

akta.pro secondary industries

Ophthalmology Pharmaceuticals (HLAIAAAL), Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)

Keywords

• Pharmaceutical products
• Crop protection chemicals
• Consumer health products
• Agricultural seeds
• Precision agriculture software

Headquarters

HQ city

Whippany

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Others

Revenue model

1. Pharmaceuticals: Prescription pharmaceutical products including Xarelto, Eylea, Nubeqa, Mirena, Adempas, and Aspirin Cardio. Sells to hospitals, clinics, and pharmacies through enterprise sales. Revenue from both new prescriptions and ongoing treatments.
2. Consumer Health: OTC self-care products including Aspirin, Bepanthen, Claritin, Elevit across 150+ trusted brands. Sold through retail, pharmacy, and e-commerce channels to individual consumers.
3. Crop Science: Agricultural products including seeds (PRECEON, Intacta, Xtendflex), crop protection (herbicides, fungicides, insecticides), and digital farming tools. Sold to farmers and agricultural businesses through dealer networks.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

Bayer is a global life science company operating three divisions: Pharmaceuticals (prescription drugs for cardiology, oncology, women's health, hematology, ophthalmology, and radiology imaging), Consumer Health (over-the-counter self-care products such as Aspirin, Claritin, Bepanthen, Elevit, and One A Day across 150+ trusted brands), and Crop Science (agricultural seeds, crop protection chemicals including Roundup, and the FieldView digital farming platform). The company invests €5.8 billion annually in R&D across a global workforce of 88,078 employees and operates in 80+ countries.

Product overview

Bayer is a life science company organized in three divisions: Pharmaceuticals, Consumer Health, and Crop Science. The Pharmaceuticals division offers prescription products including Xarelto (anticoagulant), Eylea (ophthalmology), Nubeqa (prostate cancer), Mirena/Kyleena/Jaydess (contraception), Kerendia (chronic kidney disease), AMBELVIST (MRI contrast agent), Adempas (pulmonary hypertension), Aspirin Cardio, and pipeline candidates asundexian (stroke), PER-001 (glaucoma), and evuzamitide (cardiac imaging). Consumer Health provides 150+ OTC brands including Aspirin, Bepanthen, Claritin, Aleve, Alka-Seltzer, Midol, One A Day, MiraLAX, and Afrin for allergy, pain, digestive health, nutrition, and skin care. Crop Science delivers seeds (PRECEON, Plenexos, Intacta, XtendFlex, newgold), crop protection (Roundup, Stryax dicamba), and digital farming (FieldView platform integrated with John Deere Operations Center). The Radiology unit includes MEDRAD MRXperion injection systems and contrast agents.

Differentiator

Problem solved

Functional benefit

Brands

• Xarelto: Prescription blood thinner/anticoagulant for cardiovascular conditions
• Eylea
• Nubeqa
• Mirena
• Adempas
• Aspirin
• Claritin
• Aleve
• Alka-Seltzer
• Bepanthen
• Elevit
• One A Day
• Midol
• PRECEON
• Intacta
• XtendFlex
• Plenexos
• newgold
• KERENDIA (finerenone)
• AMBELVIST (gadoquatrane)
• MEDRAD MRXperion
• Stryax
• Roundup
• Afrin

Products and services

• Xarelto Oral anticoagulant prescription drug for prevention and treatment of blood clots in cardiovascular and thrombosis conditions, sold to hospitals, clinics, and pharmacies.
• Eylea Intravitreal injection prescription therapy for treating age-related macular degeneration, diabetic macular edema, and other eye conditions, administered by ophthalmologists.
• Nubeqa Oral prescription therapy for treating prostate cancer, sold to oncology specialists and healthcare providers.
• Mirena/Kyleena/Jaydess Intrauterine devices for long-acting reversible contraception and treatment of heavy menstrual bleeding, prescribed by gynecologists and women's health practitioners.
• Kerendia (finerenone) Non-steroidal mineralocorticoid receptor antagonist prescription therapy for chronic kidney disease in diabetic and non-diabetic patients.
• AMBELVIST (gadoquatrane) FDA-approved intravenous macrocyclic gadolinium-based MRI contrast agent delivering 60% less gadolinium than standard contrast agents, used by radiologists for MRI imaging.
• Asundexian Investigational oral Factor XIa inhibitor prescription therapy under FDA Priority Review for prevention of secondary stroke in patients following non-cardioembolic ischemic stroke or TIA.
• PER-001 Investigational endothelin receptor antagonist intravitreal implant in Phase II development for open-angle glaucoma and diabetic retinopathy, acquired through Perfuse Therapeutics.
• Evuzamitide (iodine-124) PET/CT tracer Investigational PET radiotracer for cardiac amyloidosis diagnosis acquired from Attralus Inc., with Breakthrough Therapy Designation and Orphan Drug status.
• Adempas Prescription therapy for pulmonary hypertension, sold through specialty pharmacy channels to patients with chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension.
• Aspirin Cardio Prescription low-dose aspirin for cardiovascular risk prevention, prescribed by cardiologists and primary care physicians.
• MEDRAD MRXperion MR Injection System FDA-cleared MRI contrast injection system with 7T scanner compatibility and Imaging Scanner Interface 2 for use by radiology departments and imaging centers.
• Consumer Health OTC portfolio Over-the-counter self-care product portfolio of 150+ trusted brands spanning allergy relief (Claritin), pain (Aspirin, Aleve, Alka-Seltzer, Midol), digestive health, nutrition (One A Day, Elevit), and skin care (Bepanthen), sold through retail pharmacies, mass retailers, and e-commerce.
• Roundup herbicide Glyphosate-based broad-spectrum herbicide for agricultural and consumer weed control, sold to farmers through agricultural dealers and to consumers through retail channels.
• Stryax herbicide Low-volatility dicamba herbicide launched for the 2026 growing season for management of glyphosate-resistant broadleaf weeds in dicamba-tolerant soybeans and cotton.
• PRECEON Smart Corn System Smart Corn seed and digital farming system under Bayer's Crop Science portfolio, providing high-yield corn genetics to farmers.
• Intacta soybean seed technology Soybean seed technology with built-in herbicide tolerance traits for use in integrated weed management programs.
• XtendFlex soybean seed technology Soybean seed technology tolerant to multiple herbicides (dicamba, glyphosate, and glufosinate) for flexible weed control in soybean farming.
• newgold seed brand Multi-crop seed brand for low-carbon intensity crops such as camelina and winter canola, positioning farmers to participate in the biofuels market and energy transition.
• FieldView Digital Farming Platform Digital farming platform integrating agronomic data, yield maps, satellite imagery, and prescriptions; linked with John Deere Operations Center for wireless data transfer, sold to farmers and agricultural businesses.
• Afrin Nasal Spray OTC nasal decongestant spray for cold and allergy relief sold through retail pharmacy and mass retail channels.
• MiraLAX laxative OTC laxative product including a top-selling soft chew format, sold through retail pharmacy and mass retailer channels.

Quantifiable outcome

• 9 positive Phase III readouts announced since November 2023 in Pharmaceuticals division
• +5 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability16 records

Feature6 records

Partnerships

Three partnerships are on record, tiered strategic and core.

• Perfuse TherapeuticsstrategicStrategic or Co-development Partner · 7 May 2026Acquisition valued at up to $2.45 billion including $300 million upfront plus developmental, regulatory, and commercial milestones. Gives Bayer full rights to PER-001, investigational endothelin receptor antagonist in Phase II for glaucoma and diabetic retinopathy.
• John DeerecoreTechnology or Integration · 27 February 2026Partnership to launch wireless integrated farm data transfer linking Bayer's FieldView platform with John Deere's Operations Center, enabling agronomic prescriptions to move directly to farm equipment. Planned for 2026 U.S. season with global expansion to follow.
• Recursion PharmaceuticalsstrategicTechnology or Integration · 1 January 2021AI-driven drug discovery partnership for fibrotic disease therapeutics featuring hybrid structure with $30 million upfront, $20 million equity investment, up to $100 million in research milestones, and over $550 million in potential commercial milestones with tiered royalties. Partnership leverages Recursion's phenomic platform for drug discovery.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Sanofi: European pharmaceutical major with prescription and consumer health divisions. Overlaps with Bayer in consumer health/OTC and in specialty pharma, particularly cardiovascular and women's health.
• Haleon: Pure-play consumer health company spun out of GSK, with comparable OTC portfolios in pain relief, oral health, and vitamins. Direct competitor to Bayer Consumer Health's Aspirin, Claritin, and One A Day brands.
• Pfizer: Global pharmaceutical company with similar diversified prescription drug portfolio spanning cardiology, oncology, and vaccines. Both companies face patent cliff dynamics and compete for similar specialist physician relationships and hospital formularies.
• Novartis: Swiss pharmaceutical major with overlapping therapeutic areas in cardiology, oncology, and ophthalmology. Comparable in scale and structure as a Europe-headquartered branded pharmaceuticals company investing heavily in specialty and innovative medicines.
• Merck KGaA: German life sciences company spanning healthcare, life science tools, and electronics. Comparable as a diversified German-headquartered science company with both pharma and broader life science operations.
• Corteva: U.S. agriculture company specializing in seeds and crop protection. Direct competitor to Bayer Crop Science in corn and soybean seeds, with comparable herbicide and trait portfolios.
• Roche: Swiss pharmaceutical leader with strong oncology, diagnostics, and ophthalmology franchises. Direct overlap with Bayer in cancer therapeutics and radiopharmaceutical/diagnostic imaging adjacencies.
• AstraZeneca: Global biopharmaceutical company with major oncology, cardiovascular, and rare disease franchises. Competes with Bayer in oncology (Nubeqa) and cardiovascular care (Xarelto).
• GSK: British pharmaceutical and consumer healthcare company with established OTC franchises (Sensodyne, Panadol) competing with Bayer's Claritin, Aspirin, and Aleve. Strong in respiratory and vaccines.

Broad incumbents

• BASF: German chemical company with significant agricultural solutions (crop protection, seeds) and broader industrial chemical operations. Comparable as a diversified German life sciences/chemicals peer with similar Crop Science positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat8 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/bayerus
• Facebookfacebook.com/BayerUnitedStates
• LinkedInlinkedin.com/company/bayer

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bayer